Simeprevir (Olysio) and sofosbuvir (Sovaldi) are direct-acting antiviral drugs. They block specific proteins the hepatitis C virus needs to multiply and spread. This combination is one of the recommended regimens for people with virus genotype 1 who have not yet been treated for hepatitis C.
This answer was adapted from Sharecare's award-winning AskMD app. Start a consultation now to find out what's causing your symptoms, learn how to manage a condition, or find a doctor.
Continue Learning about Hepatitis C
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.